REYON Pharmaceutical Co., Ltd. (102460.KS) KSC

Currency In KRW

AD

Valuation

Market Cap200.37B
Enterprise Value409.82B
P/E Ratio-4.41
PEG Ratio0.05
Price/Sales Ratio1.24
Price/Book Ratio0.86
Enterprise/Revenue2.72
Enterprise/EBITDA-158.61

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.28
Operating Margin-0.23
AD

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.18

Income Statement

Revenue145.93B
Revenue/Share7,917.87
Gross Profit33.76B
EBITDA228.1M
Net Income-29.83B
Diluted EPS-1,604.66

Balance Sheet

Total Cash4.35B
Total Cash/Share237.22
Total Debt219.17B
Total Debt/Equity1.05
Current Ratio0.52
Book Value Per Share11,427.07

Price History

52-Week Change-11.44
52-Week High14,430
52-Week Low9,100
Moving Average 50 Days10,660.2
Moving Average 200 Days10,985

Statistics

Average Volume93,982
Shares Outstanding18.34M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor51:50
Last Split DateDecember 29, 2020
AD